Skye Bioscience Non-Current Deferred Revenue (Quarterly) Analysis

Skye Bioscience, Inc. (SKYE)

0.9807 +0.04 (+4.21%) USD | NASDAQ | Jan 13, 16:00

0.9807 0.00 (0.00%) After-Hours: 16:34

View Non-Current Deferred Revenue (Quarterly) for SKYE.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Non-Current Deferred Revenue (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Non-Current Deferred Revenue (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Non-Current Deferred Revenue (Quarterly) Benchmarks

Start Trial

Perspective Therapeutics, Inc.	Upgrade
Theravance Biopharma, Inc.	--
Viking Therapeutics, Inc.	--
Kyntra Bio, Inc.	Upgrade
Myomo, Inc.	--